Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis and non-cystic fibrosis bronchiectasis
Keywords:
Aspergillus, Allergic bronchopulmonary aspergillosis, Bronchiectasis, Cystic fibrosis, Fungal antibodiesAbstract
Background: Aspergillus sensitization (AS) and allergic bronchopulmonary aspergillosis (ABPA) can occur as a cause of permanent lung damage in patients with cystic fibrosis (CF) and non-CF bronchiectasis. Objective: The aim of this study was to determine the frequency of AS and ABPA in patients with CF and non-CF bronchiectasis in southwestern Iran. Methods: This cross-sectional study was conducted on 33 patients with CF and 27 patients with non-CF bronchiectasis from southwestern Iran who were referred to Namazi Hospital affiliated to Shiraz University of Medical Sciences from July 2015 to February 2016. Skin prick test to Aspergillus fumigatus, peripheral blood eosinophil count, total serum IgE, specific IgE and IgG against Aspergillus fumigatus as well as radiologic chest studies were done for each patient. Statistical analysis was done by Mann-Whitney U test, Fisher Exact test, and Kappa weighted in SPSS software version 18. Level of significance was set at p<0.05. Results: Nine patients with CF (27.3%) and one patient with non-CF bronchiectasis (3.7%) had positive skin tests to Aspergillus. There was 81.2% agreement between positive skin test and specific IgE to Aspergillus fumigatus (p<0.001). Three patients with CF (9%) met the diagnostic criteria for ABPA, whereas ABPA was not seen in patients with non-CF bronchiectasis. Conclusion: ABPA was low in this study, considering more frequency of AS in patients with cystic fibrosis, clinicians should keep in mind the diagnosis of ABPA for those CF patients that do not respond to usual medical therapy and have positive skin tests to Aspergillus allergens.
References
Elborn JS. Cystic fibrosis. Lancet. 2016; 388(10059): 2519-31. doi: 10.1016/S0140-6736(16)00576-6.2)Kuca K, Klimova B, Novotny M, Maresova P. Cystic Fibrosis Revisited-a Review Study. Med Chem.2017; 13(2): 102-9. doi: 10.2174/1573406412666160608113235.3)Farjadian S, Moghtaderi M, Kashef S, Alyasin S, Najib K, Saki F. Clinical and genetic features in patientswith cystic fibrosis in southwestern Iran. Iran J Pediatr. 2013; 23(2): 212-5. PMID: 23724185, PMCID:PMC3663315.4)Liu JC, Modha DE, Gaillard EA. What is the clinical significance of filamentous fungi positive sputumcultures in patients with cystic fibrosis? J Cyst Fibros. 2013; 12(3): 187-93. doi: 10.1016/j.jcf.2013.02.003.PMID: 23491855.5)Saunders RV, Modha DE, Claydon A, Gaillard EA. Chronic Aspergillus fumigatus colonization of thepediatric cystic fibrosis airway is common and may be associated with a more rapid decline in lungfunction. Med Mycol. 2016; 54(5): 537-43.6)Jones AM, Horsley A, Denning DW. What is the importance of classifying Aspergillus disease in cysticfibrosis patients? Expert Rev Respir Med. 2014; 8: 389-92. doi: 10.1586/17476348.2014.915751. PMID:24869560.7)Menzies D, Holmes L, McCumesky G, Prys-Picard C, Niven R. Aspergillus sensitization is associated withairflow limitation and bronchiectasis in severe asthma. Allergy. 2011;66: 679–85. doi: 10.1111/j.1398-9995.2010.02542.x. PMID: 21261660.8)Maturu VN, Agarwal R. Prevalence of Aspergillus sensitization and allergic bronchopulmonaryaspergillosis in cystic fibrosis: systematic review and meta-analysis. Clin Exp Allergy. 2015; 45(12): 1765-78. doi: 10.1111/cea.12595. PMID: 26177981.9)Mastella G, Rainisio M, Harms HK, Hodson ME, Koch C, Navarro J, et al. Allergic bronchopulmonaryaspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of CysticFibrosis. Eur Respir J. 2000; 16(3): 464-71
Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis JF, Guleria R, et al. Allergic bronchopulmonaryaspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin ExpAllergy. 2013; 43: 850-73. doi: 10.1111/cea.12141.PMID: 23889240.11)Moss RB. Fungi in cystic fibrosis and non-cystic fibrosis bronchiectasis. Semin Respir Crit Care Med.2015; 36(2): 207-16. doi: 10.1055/s-0035-1546750. PMID: 25826588.12)McShane PJ, Naureckas ET, Tino G, Strek ME. Non-cystic fibrosis bronchiectasis. Am J Respir Crit CareMed. 2013; 188(6): 647-56. doi: 10.1164/rccm.201303-0411CI. PMID: 23898922.13)Altenburg J, Wortel K, van der Werf TS, Boersma WG. Non-cystic fibrosis bronchiectasis: clinicalpresentation, diagnosis and treatment, illustrated by data from a Dutch Teaching Hospital. Neth J Med.2015; 73(4): 147-54. PMID: 25968285.14)Dodd JD, Lavelle LP, Fabre A, Brady D. Imaging in cystic fibrosis and non-cystic fibrosis bronchiectasis.Semin Respir Crit Care Med. 2015; 36(2): 194-206. doi: 10.1055/s-0035-1546749. PMID: 25826587.15)Singh M, Rebordosa C, Bernholz J, Sharma N. Epidemiology and genetics of cystic fibrosis in Asia: Inpreparation for the next-generation treatments. Respirology. 2015; 20(8): 1172-81. doi:10.1111/resp.12656. PMID: 26437683.16)Jalalirad M, Houshmand M, Mirfakhraie R, Goharbari MH, Mirzajani F. First study of CF mutations in theCFTR gene of Iranian patients: detection of DeltaF508, G542X, W1282X, A120T, R117H, and R347Hmutations. J Trop Pediatr. 2004; 50(6): 359-61. doi: 10.1093/tropej/50.6.359. PMID: 15537723.17)Valletta E, Braggion C, Mastella G. Sensitization to Aspergillus and allergic bronchopulmonaryaspergillosis in a cystic fibrosis population. Pediatr Asthma Allergy Immunol. 1993; 7: 43-9. doi:10.1089/pai.1993.7.43.18)Geller DE, Kaplowitz H, Light MJ, Colin A. Allergic bronchopulmonary aspergillosis in cystic fibrosis.Reported prevalence, regional distribution, and patient characteristics. Chest. 1999; 116(3): 639-46. PMID:10492265.19)Carneiro AC, Lemos AC, Arruda SM, Santana MA. Prevalence of allergic bronchopulmonaryaspergillosisin patients with cystic fibrosis in the state of Bahia, Brazil. J Bras Pneumol. 2008; 34(11): 900-6. PMID:19099095.20)Moghtaderi M, Farjadian S, FereidouniM, Nasiri M, Nejat A. Indoor Dust Allergen Levels in the Homesof Patients with Childhood Asthma: An Experience From Southwestern Iran. Iran J Allergy AsthmaImmunol. 2016; 15(2): 132-7. PMID: 27090366.21)Sharma VK, Raj D, Xess I, Lodha R, Kabra SK. Prevalence and risk factors for allergic bronchopulmonaryaspergillosis in Indian children with cystic fibrosis. Indian Pediatr. 2014; 51(4): 295-7. PMID: 24825267.22)Sehgal IS, Dhooria S, Bal A, Agarwal R. Allergic bronchopulmonary aspergillosis in an adult withKartagener syndrome. BMJ Case Rep. 2015; 2015. doi: 10.1136/bcr-2015-211493.23)Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol.2002; 110(5): 685-92.24)Stevens DA, Kan VL, Judson MA, Morrison VA, Dummer S, Denning DW, et al. Practice guidelines fordiseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis. 2000; 30(4): 696-709.25)Ryan MW, Marple BF. Allergic fungal rhinosinusitis: diagnosis and management. Curr Opin OtolaryngolHead Neck Surg. 2007; 15(1): 18-22.26)Barton RC, Hobson RP, Denton M, Peckham D, Brownlee K, Conway S, et al. Serologic diagnosis ofallergic bronchopulmonary aspergillosis in patients with cystic fibrosis through the detection ofimmunoglobulin G to Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2008; 62(3): 287-91.27)Agarwal R. Allergic bronchopulmonary aspergillosis. Chest. 2009; 135(3): 805-26.28)Tepper LA, Caudri D, Rovira AP, Tiddens HA, de Bruijne M. The development of bronchiectasis on chestcomputed tomography in children with cystic fibrosis: can pre-stages be identified? Eur Radiol. 2016;26(12): 4563-9. doi: 10.1007/s00330-016-4329-z. PMID: 27108295 PMCID: PMC5101271.29)StickSM, Brennan S, Murray C, Douglas T, von Ungern-Sternberg BS, Garratt LW, et al. Bronchiectasisin infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr. 2009;155(5): 623-8.e1. doi: 10.1016/j.jpeds.2009.05.005. PMID: 19616787.30)Walicka-Serzysko K, Sands D. The clinical presentations of pulmonary aspergillosis in children with cysticfibrosis-preliminary report. Dev Period Med. 2015; 19(1): 66-79.31)Hutcheson PS, Rejent AJ, Slavin RG. Variability in parameters of allergic bronchopulmonary aspergillosisin patients with cystic fibrosis. J Allergy Clin Immunol. 1991; 88(3 Pt 1): 390-4.
Published
Issue
Section
License
Copyright (c) 2020 Knowledge Kingdom Publishing
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
